In Industry News


The Health and Food Safety Directorate-General of the European Commission has launched calls for expressions of interest to represent civil society in two scientific committees of the European Medicines Agency (EMA): the Pharmacovigilance Risk Assessment Committee (PRAC) and the Committee for Advanced Therapies (CAT).

The role of patients’ organisation representatives in the CAT and PRAC is to ensure that patients’ needs and views are taken into account in all the discussions of the committees.

Read the full article here

Recent Posts